In this context, DNA methylation in different genes and tissues (including insulin-producing pancreatic β-cells, insulin-sensitive tissues and blood) have been proposed as the biomarkers of insulin secretion/sensitivity, biomarkers of glycemic responses after glucose challenges, or directly as biomarkers of T2D [11,12,13]. The gene discussed is INS; the disease is type 2 diabetes mellitus.